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• Spaceflight is a unique environment characterized by stress,
microgravity, isolation, circadian misalignment, and radiation
exposure and impacts immune health.
• Planned long duration missions to Mars are a top priority for
NASA and mitigating the negative health consequences of
spaceflight is particularly important. Terrestrial analogs are a vital
aspect of spaceflight research since data from astronauts is
limited and it is costly to receive samples from ISS. The most
relevant ground analog would include station lifestyle, stress,
disrupted circadian rhythms and isolation.
• This analysis compares various aspects of immune dysregulation
in astronauts during long-duration orbital spaceflight to ground-
analogs. Astronaut data were also compared to a clinical
immunodeficiency population, shingles patients, to help interpret
clinical risks during deep space missions.
• A comprehensive evaluation was performed across hypoxic
interior Antarctica, normoxic coastal Antarctica, HERA, and
astronauts which included plasma and mitogen stimulated
cytokine profiles, T-cell function, and peripheral leukocyte
distribution. A cross platform analysis was then performed to
define in-flight immune alterations, determine analog
appropriateness, and interpret clinical risk.
INTRODUCTION
Blood samples were collected before, during and after mission ISS, Antarctica winterover,
and HERA crewmembers. Whole blood was stained with monoclonal antibodies (CD45,
CD3, CD4, CD8, CD14, CD19, CD56, CD69, etc.), lysed, and washed for phenotype analysis
by flow cytometry. Whole blood was centrifuged and plasma removed, aliquoted, and
frozen for later cytokine analysis. Peripheral blood mononuclear cells (PBMCs) were
isolated using standard density gradient centrifugation techniques. Whole blood (100 uL)
was used for cultures of HERA samples. Cultures were set up as described in Table 1.
Table 1: Cultures Set-up
Supernatant was removed following a 24-hour incubation and cells were stained with
monoclonal antibodies, CD3, CD4, CD8, CD25, and CD69. Samples from Concordia were
then frozen with 10% DMSO and shipped back to NASA Johnson Space Center for analysis
upon conclusion of the mission, ISS and HERA samples were analyzed immediately. The
proportions of CD4+ and CD8+ T-cells expressing CD25 and CD69 were assessed using a
Beckman Coulter Gallios flow cytometer.
Following the 48-hour incubations, supernatant was removed and frozen for subsequent
batch analysis. The concentrations of 13 cytokines were measured in the supernatant using
a commercially available magnetic multiplex assay (EMD Millipore) and a Luminex®
MAGPIX® instrument.
Blood samples were collected from Shingles patients upon presentation, centrifuged, and
plasma removed and frozen for subsequent batch analysis of cytokines.
Paired Student’s t tests were performed comparing each mission day to the baseline
sample, to determine if the in mission and post mission samples were significantly
different (p < 0.05) from the baseline sample.
METHODS
Mitogen
Mitogen 
Concentration
Number of 
PBMCs
Incubation 
Time
SEA+SEB 10 µg SEA
10 µg SEB
1×106 24 hours
Anti-CD3/CD28 0.125 µg CD3
0.25 µg CD28
1×106 24 hours
LPS 10 µg 1×106 48 hours
Anti-CD3/CD28 0.125 µg CD3
0.25 µg CD28
1×106 48 hours
PMA+I 10 ng PMA
2 µg Ionomycin
1×106 48 hours
RESULTS
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Figure 5. CD4+ and CD8+ T-cell early (CD69+) and late (CD69+/CD25+) activation following a 24-
hour culture of PBMCs or whole blood with the indicated mitogen. Samples were processed
before, during and after mission. Data are presented as mean.
DISCUSSION
Peripheral Leukocyte Distribution
Figure 3. Plasma cytokine concentrations were measured before, during and after mission. Data
in line graphs are presented as mean plasma concentration (pg/mL) normalized to baseline.
• Astronauts manifest a distinct pattern of immune alterations, including relatively 
unaltered leukocyte distribution, reduced T/NK cell function, and increases in plasma 
cytokine concentrations leading to the reactivation of latent herpesviruses. 
• Immune alterations during interior Antarctic winterover at Concordia station were 
dissimilar from spaceflight, likely due to hypobaric hypoxia. Normoxic winterover at 
Neumayer station, to date only cytokine data exist, appears more homologous to 
spaceflight. 
• The Human Exploration Research Analog (HERA) at NASA Johnson Space Center shows 
the least similarities to spaceflight.
• The pattern is similar to that observed in shingles patients, but reduced in magnitude. 
• Stress induced reductions in immunity can lead to clinical disease. This phenomenon 
may represent a continuum, where alterations in astronauts may represent more subtle 
variations which precede the development of disease. Antarctica data, at a magnitude 
between flight and disease, suggest that stress and circadian issues may be a primary 
contributor. 
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Figure 1. Whole blood was stained with monoclonal antibodies and analyzed by flow cytometry 
to determine leukocyte distribution. Concordia blood samples were frozen with 10% DMSO and 
shipped to NASA Johnson Space Center upon mission completion for processing and analysis.
Figure 2. Secreted cytokine concentrations measured in culture supernatant following a 48-hour 
culture of PBMC or whole blood with the indicated mitogen. Samples were collected and 
processed before, during and after mission. Line graphs are presented as mean concentration 
(pg/mL) normalized to baseline
Figure 4. Plasma was collected from Shingles patients at presentation and cytokine analysis was 
performed. This data was then compared to plasma cytokine data from normal, healthy adults 
and ISS crewmembers at flight day 30.
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